Newsquawk Logo

Abbott Laboratories (ABT) Q1 2026 (USD): Adj. EPS 1.15 (exp. 1.15), Revenue 11.2bln (exp. 11.00bln)

Importance
Level 1

Outlook

  • Q2 adj. EPS 1.25-1.32 (exp. 1.37).
  • FY26 adj. EPS 5.38-5.58 (exp. 5.61).